COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

The outbreak of coronavirus disease 2019 (COVID-19) has involved more than 159 countries and more than 5 million people worldwide. A 40-year-old man with a history of rheumatoid arthritis treated with prednisolone, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), and biologic agents was admitted wit...

Full description

Bibliographic Details
Main Authors: Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee
Format: Article
Language:English
Published: PAGEPress Publications 2020-11-01
Series:Reumatismo
Subjects:
COVID-19 pandemic
biological therapy
rheumatologic disorders.
Online Access:https://www.reumatismo.org/index.php/reuma/article/view/1289

Similar Items

Similar Items